{
"NDC": {
"NDCCode": "24571-108-06",
"PackageDescription": "2 BAG in 1 CASE (24571-108-06) / 5 L in 1 BAG",
"NDC11Code": "24571-0108-06",
"ProductNDC": "24571-108",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Prismasol",
"ProprietaryNameSuffix": "Bgk0/2.5",
"NonProprietaryName": "Calcium Chloride, Magnesium Chloride, Dextrose Anhydrous, Lactic Acid, Sodium Chloride, And Sodium Bicarbonate",
"DosageFormName": "INJECTION",
"RouteName": "INTRAVENOUS",
"StartMarketingDate": "20061025",
"EndMarketingDate": null,
"MarketingCategoryName": "NDA",
"ApplicationNumber": "NDA021703",
"LabelerName": "Vantive US Healthcare LLC",
"SubstanceName": "ANHYDROUS DEXTROSE; CALCIUM CHLORIDE; LACTIC ACID; MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE",
"StrengthNumber": "20; 3.68; 5.4; 3.05; 3.09; 6.46",
"StrengthUnit": "g/L; g/L; g/L; g/L; g/L; g/L",
"Pharm_Classes": "Acidifying Activity [MoA], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2025-07-09",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20061025",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}